{"transactions":[{"id":2181518,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":124470,"kind":"person","name":"Peters Jeffrey J","position":1,"cik":"0001329814","reported_name":"Peters Jeffrey J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.000001 par value","published_at":"2022-08-17T20:50:52.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":215415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, and vest and become issuable on August 15, 2023, conditioned upon the reporting person remaining a director of Xtant through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 215,415 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, conditioned upon the reporting person remaining a director of Xtant through the vesting date."}],"balance_after":448546,"source":{"system":"sec-edgar","filing":"0001235802-22-000099","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580222000099/primary_doc.xml","form_type":"4"}},{"id":2599972,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":124470,"kind":"person","name":"Peters Jeffrey J","position":1,"cik":"0001329814","reported_name":"Peters Jeffrey J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.000001 par value","published_at":"2021-08-17T21:11:36.000Z","date":"2021-08-15","kind":"grant","acquired":true,"shares":85337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, and vest and become issuable on August 15, 2022, conditioned upon the reporting person remaining a director of Xtant through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 143,436 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, conditioned upon the reporting person remaining a director of Xtant through the vesting date."}],"balance_after":233131,"source":{"system":"sec-edgar","filing":"0001235802-21-000106","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580221000106/primary_doc.xml","form_type":"4"}},{"id":3284429,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":124470,"kind":"person","name":"Peters Jeffrey J","position":1,"cik":"0001329814","reported_name":"Peters Jeffrey J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.000001 par value","published_at":"2020-02-07T21:28:15.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":116197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, and will vest and become issuable with respect 58,098 shares on February 15, 2021 and with respect to 58,099 shares on February 15, 2022, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 116,197 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, conditioned upon the reporting person remaining a director of Xtant through the vesting date; (ii) 5,555 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, conditioned upon the reporting person remaining a director of Xtant through the vesting date, and (iii) 13,021 shares issued as part of a restricted stock award granted under the Amended and Restated Xtant Equity Incentive Plan, which shares are subject to forfeiture until vested."}],"balance_after":147794,"source":{"system":"sec-edgar","filing":"0001235802-20-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580220000005/primary_doc.xml","form_type":"4"}},{"id":3406285,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":124470,"kind":"person","name":"Peters Jeffrey J","position":1,"cik":"0001329814","reported_name":"Peters Jeffrey J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.000001 par value","published_at":"2019-09-25T20:29:46.000Z","date":"2019-09-24","kind":"grant","acquired":true,"shares":5555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan and will vest and become issuable on February 15, 2020, conditioned upon the reporting person remaining a director of Xtant through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,555 shares to be issued upon vesting pursuant to restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, conditioned upon the reporting person remaining a director of Xtant through the vesting date, and 13,021 shares issued as part of a restricted stock award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, which shares are subject to forfeiture until vested."}],"balance_after":31597,"source":{"system":"sec-edgar","filing":"0001235802-19-000121","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580219000121/primary_doc.xml","form_type":"4"}},{"id":3841661,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":124470,"kind":"person","name":"Peters Jeffrey J","position":1,"cik":"0001329814","reported_name":"Peters Jeffrey J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.000001 par value","published_at":"2018-08-16T21:09:57.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":26042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued pursuant to a restricted stock award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, such shares will vest with respect to 13,021 shares on each of February 15, 2019 and February 15, 2020 and are subject to forfeiture until vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares were issued pursuant to a restricted stock award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, such shares will vest with respect to 13,021 shares on each of February 15, 2019 and February 15, 2020 and are subject to forfeiture until vested."}],"balance_after":26042,"source":{"system":"sec-edgar","filing":"0001235802-18-000124","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580218000124/primary_doc.xml","form_type":"4"}}]}